✦ LIBER ✦

Erectile dysfunction and cardiovascular considerations: Managing patients effectively with phosphodiesterase type 5 inhibitors

✍ Scribed by Adolph M. Hutter Jr.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phosphodiesterase type 5 inhibitors for

✍ Vickers, M A; Satyanarayana, R 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 97 KB

Toward a new ‘EPOCH’: optimising treatme

✍ R. Sadovsky; G. B. Brock; S. W. Gutkin; S. Sorsaburu 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 962 KB

Cardiovascular effects of sildenafil in

✍ Salvi, F; Sarzani, R; Giorgi, R; Donatelli, G; Pietrucci, F; Micheli, A; Baldoni 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 27 KB

Patterns of switching phosphodiesterase

✍ D. Hatzichristou; J. M. Haro; A. Martin-Morales; A. Von Keitz; A. Riley; J. Bert 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 291 KB

Evaluation and diagnostic testing of ere

✍ Kenneth Jacobsohn; Run Wang 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 134 KB

Efficiency of Combined Therapy with Impa

✍ Kh. S. Ibishev 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 258 KB